Abstract
A 1.0% gel formulation of C31G, a surfactant, has been shown to have in vitro antiviral and antibacterial activity. The goal of this study was to evaluate the safety and efficacy of vaginal and rectal applications of 1.0% Savvy (C31G) in the nonhuman primate model. The safety of repeated 1.0% C31G application was evaluated by microflora, pH, vaginal biopsy, colposcopy, and rectal lavage. Efficacy in preventing chlamydial infection was documented by culture, nucleic acid amplification tests, and serology. Repeated applications of Savvy (1.0% C31G) were not associated with significant changes in pH, microflora, or inflammatory infiltrates on tissues. No significant differences in epithelial desquamation were noted after rectal product use compared with placebo. Four of 6 animals were protected from chlamydial infection after pretreatment with Savvy. C31G was shown to be safe to both vaginal and rectal mucosal tissues and to the microflora with repeated daily use. Savvy has an acceptable safety profile after repeated vaginal and rectal use. A single intravaginal application of 1.0% C31G provided partial protection from acquiring cervical chlamydial infection.
References
Mar 1, 1975·Journal of Clinical Microbiology·S P WangK K Holmes
Mar 1, 1988·Antimicrobial Agents and Chemotherapy·A M CornerD Malamud
Apr 1, 1983·Journal of Clinical Microbiology·W E StammL Cles
Jun 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E J BaronS M Finegold
Nov 1, 1996·Sexually Transmitted Diseases·D L PattonS L Hillier
Nov 1, 1996·Sexually Transmitted Diseases·D L PattonS L Hillier
Feb 1, 1997·The Journal of Antimicrobial Chemotherapy·D ZakulaR C Goldman
Jun 1, 1997·Antimicrobial Agents and Chemotherapy·P B WyrickD Malamud
May 18, 1999·American Journal of Obstetrics and Gynecology·D L PattonS L Hillier
Nov 7, 1999·Antiviral Research·F C KrebsB Wigdahl
Jul 19, 2001·Sexually Transmitted Diseases·D L PattonS L Hillier
Oct 9, 2002·Sexually Transmitted Diseases·Dorothy L PattonSharon L Hillier
Jan 9, 2003·Journal of Clinical Microbiology·C A GaydosJ Schachter
Apr 27, 2004·Sexually Transmitted Diseases·D L PattonS L Hillier
Mar 29, 2005·Antimicrobial Agents and Chemotherapy·Bradley J CataloneBrian Wigdahl
Apr 27, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Sharon L HillierFulvia Veronese
Citations
Jun 27, 2007·AIDS and Behavior·Kathleen M Morrow, Monica S Ruiz
Nov 6, 2013·Antiviral Research·Lisa C RohanLin Wang
Feb 17, 2010·AIDS Research and Human Retroviruses·Gregory T SpearRonald S Veazey
May 21, 2011·AIDS Research and Human Retroviruses·Paria MirmonsefGregory T Spear
Mar 8, 2008·ILAR Journal·Murray B Gardner, Paul A Luciw
Apr 18, 2009·Current Opinion in HIV and AIDS·Ronald S Veazey
Mar 20, 2009·Sexually Transmitted Diseases·Kathleen L VincentMassoud Motamedi
Jun 27, 2009·Sexually Transmitted Diseases·Dorothy L PattonKathleen J Paul
Aug 9, 2008·Theoretical Biology & Medical Modelling·Misaki WayengeraWilson Byarugaba
Feb 9, 2012·The Indian Journal of Medical Research·Gita Ramjee
Oct 9, 2007·Journal of Pharmaceutical Sciences·Alexandra B SassiLisa C Rohan
Aug 29, 2007·Journal of Pharmaceutical Sciences·Bonnie E LaiDavid F Katz
Sep 18, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Rute NunesJosé das Neves
Feb 19, 2008·Contraception·Christine K MauckKurt Barnhart
Oct 25, 2011·Journal of Medical Primatology·Dorothy L Patton
Dec 30, 2014·Advanced Drug Delivery Reviews·José A Fernández-RomeroMelissa Robbiani
Nov 14, 2006·Biologicals : Journal of the International Association of Biological Standardization·Ian McGowan
Aug 2, 2011·AIDS Research and Therapy·Alexandra B SassiLisa C Rohan
Jul 19, 2013·Antiviral Research·James M HillHarris E McFerrin
Jul 9, 2008·Sexually Transmitted Diseases·Dorothy L PattonKathleen J Paul
Sep 25, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Ian McGowanPeter A Anton
Dec 20, 2007·Sexually Transmitted Diseases·Kathleen L VincentMassoud Motamedi
Nov 10, 2010·AIDS·Gita RamjeeSheena McCormack
Dec 19, 2009·Pharmaceutical Development and Technology·David R Friend
Apr 18, 2009·Current Opinion in HIV and AIDS·Ian McGowan, Peter Anton